Sheaff Brock Investment Advisors LLC Acquires Shares of 3,346 SPDR S&P Biotech ETF (XBI)

Sheaff Brock Investment Advisors LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,346 shares of the exchange traded fund’s stock, valued at approximately $290,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quantitative Investment Management LLC raised its stake in SPDR S&P Biotech ETF by 642.3% in the second quarter. Quantitative Investment Management LLC now owns 1,451,998 shares of the exchange traded fund’s stock valued at $112,065,000 after buying an additional 1,256,398 shares in the last quarter. Assetmark Inc. raised its stake in SPDR S&P Biotech ETF by 59.9% in the third quarter. Assetmark Inc. now owns 1,239,051 shares of the exchange traded fund’s stock valued at $107,265,000 after buying an additional 464,246 shares in the last quarter. SG Americas Securities LLC raised its stake in SPDR S&P Biotech ETF by 162.8% in the third quarter. SG Americas Securities LLC now owns 303,622 shares of the exchange traded fund’s stock valued at $26,285,000 after buying an additional 188,106 shares in the last quarter. NF Trinity Capital Hong Kong Ltd acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at $10,302,000. Finally, Tavio Capital LLC acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at $10,027,000.

Shares of SPDR S&P Biotech ETF (XBI) traded down $0.60 during mid-day trading on Wednesday, hitting $79.75. The company’s stock had a trading volume of 3,513,300 shares, compared to its average volume of 4,220,747. SPDR S&P Biotech ETF has a 12 month low of $58.66 and a 12 month high of $88.98.

COPYRIGHT VIOLATION NOTICE: This report was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://stocknewstimes.com/2017/12/06/sheaff-brock-investment-advisors-llc-acquires-shares-of-3346-spdr-sp-biotech-etf-xbi.html.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply